Prednisolone Tablets BP (VET) 5mg 28 pack

4.1. Target species Dog and cat. 4.2 Indications for use As an anti-inflammatory and anti-allergenic agent in either species. Prednisolone has found to be useful, often as an adjunct to other agents, in the treatment of tumours. 4.3 Contra-indications Administration is contra-indicated where corneal ulceration is present. Administration is generally contra-indicated if renal disease or diabetes mellitus is present. 4.4 Special warnings Administration may render concurrent vaccination inoperative. 4.5 Special precautions The lowest effective dose should be used. Treatment should not be withdrawn suddenly and in many situations a dosage schedule with falling dose will be found of use. Some cases may require continuing therapy, the minimum effective maintenance dose should be established. Special precautions for use in animals It is generally considered that problems associated with the induction of adrenal insufficiency are minimised by dosing once every alternate morning for dogs and every alternate evening for cats. Following long or medium term treatment the dosage should be reduced gradually. Special precautions to be taken by the person administering the veterinary medicinal product to animals Impermeable gloves should be worn whilst administering the product. Take care to avoid accidental eye contact. If eye contact occurs, wash thoroughly with clean running water. Wash hands after use. 4.6 Adverse reactions Prednisolone, as with other corticosteroids, has a wide range of effects. Polydipsia, polyurea and polyphagia are common observations. These side effects often diminish as therapy proceeds. Cushingoid symptoms may be provoked and should be monitored for. Consideration should be given to the potential effects of corticosteroids on wound healing and/or the body’s ability to deal with infection. Symptoms of infection may be masked or atypical. Careful consideration should be given as to the desirability of administration to patients with systemic infections, if specific anti-infective is neither possible nor instigated. In the presence of viral infection, corticosteroids may worsen or hasten the progress of the disease. Gastrointestinal ulceration has been reported in animals treated with corticosteroids. 4.7 Pregnancy and lactation Prednisolone is not recommended for use in pregnant animals. Administration of corticosteroids in early pregnancy is known to cause foetal abnormalities in laboratory animals. Administration in late pregnancy may cause early parturition. 4.8 Interactions Gastrointestinal ulceration may be exacerbated by corticosteroids in patients given non-steroidal anti-inflammatory drugs.
Vat Rate: 20%